Home › Ipsen Announces A Step Forward In The Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S.
 

Keywords :   


Ipsen Announces A Step Forward In The Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S.

2014-05-16 10:04:38| foodingredientsonline Home Page

Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced that a supply of Increlex (mecasermin [rDNA origin] injection) will be available in the U.S. starting June 2, 2014

Tags: the us step forward

Category:Food and Related Products

Latest from this category

All news
»
04.11Tropical Depression Eighteen Graphics
04.11Tropical Depression Eighteen Public Advisory Number 4A
04.11Remnants of Patty Graphics
04.11Atlantic Tropical Weather Outlook
04.11Eastern North Pacific Tropical Weather Outlook
04.11Paper Excellence Group Rebrands as Domtar
04.11Registration Open for 2025 Waterborne Symposium
04.11ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
More »